Learn How to Beat Problems Feb23, 2007

Tchaikapharma High Quality Medicines Sofia Learn how to beat (regulatory, legal and field problems in new EU member states to ensure a smooth transition and increase your sales) the competition and benefit from the globalization Berlin February 23, 2007

Competitiveness: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Healthcare: crucial economic sector for the world society in the next 50 years(?) Source: UBS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Synergy: transforming the way our industry work ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Six Forces That Can Drive Your Company- Or Kill It ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

How do you manage these forces? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

How do you manage these forces when stuck in the middle? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MORE OF THE SAME

Remember, Einstein said: ,[object Object]

The decision: ,[object Object],[object Object],[object Object],[object Object]

Contents ,[object Object],[object Object],[object Object]

Situation Analysis : Business environment Bulgaria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Situation Analysis : Business environment Bulgaria cont’d ,[object Object],[object Object],[object Object]

Situation Analysis : Business environment Bulgaria cont’d ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bulgarian Pharmaceutical Market: 1990-2000 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bulgaria Today ,[object Object],[object Object],[object Object],[object Object],[object Object],Source: World Economic Forum Davos

The new Bulgarian modern industry Source: Daniel Kahneman Nobel Prize winner in economic sciences 2002 How do you read this?

The new Bulgarian modern industry Source: Daniel Kahneman Nobel Prize winner in economic sciences 2002 How do you read this letter?

The new Bulgarian modern industry Source: Daniel Kahneman Nobel Prize winner in economic sciences 2002 How do you read it now?

The new Bulgarian modern industry Is it a generic company?

The new Bulgarian modern industry Is it an original one?

The new Bulgarian modern industry

The new Bulgarian modern industry Is a part of CL BioPharma Group

Vertically Integrated Powerhouse on the Balkans Commercial League warehouse Tchaikapharma production site Tchaikapharma production site PROJECTED Cardiac hospital Cardiac hospital PROJECTED Haemodialysis center PROJECTED

The CL/ Tchaikapharma Advantage: Winning Concept for beating regulatory, legal and market problems ,[object Object],Trials Regulatory Manufacturing Marketing Distribution Tchaikapharma Inc Commercial League NPC Macedonia Pharmacia Distinguished Pharmacies Inc ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Medical Activities ,[object Object],[object Object],[object Object],[object Object],Bulgarian Cardiac Institute, JSC Reaching Across The Entire Value Chain

The CL/ Tchaikapharma Advantage: cont’d Winning Concept for beating regulatory, legal and market problems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

The CL/ Tchaikapharma Advantage: cont’d Winning Concept for beating regulatory, legal and market problems ,[object Object],[object Object],[object Object],[object Object],[object Object],Strategic Investment Projects

Spearheaded Entry/Re-Entry of Major Generic Players ,[object Object],Source: IMS Data

Novartis / CL BioPharma Group Generics Cooperation ,[object Object]

Case Study Enalapril (Bulk Supply from Sandoz) Market Share (# of patients) Nov ‘06 Distancing leadership position in a very crowded generic market Source: NHIF, number of patients

Case Study: ACE Inhibitors Tchaikapharma In-licensed from La Roche (results for just 3 months) and elevated Pfizer to market leader in 1.5 year time only Source: NHIF, number of patients

Case Study on own Nordipin (Amlodipine): Leader In Three Months Only Source: NHIF/ in patients

Case Study: In-licensed Dilatrend (carvedilol) Roche Market Share Nov ’06 Against Multiple Generic Entries Source: NHIF, number of patients

Case Study: In-Licensed Symbicort (AstraZeneca) Time Under CL Marketing Only Source: NHIF, number of Patients

Case Study on own Klacar (clarithromycin) : Leading Anti-infectives Brand Just Three Months After Launch Source: NHIF, Value BGN

Marketers judgment doesn’t always look like action to their colleagues in Sales ( Stop Einstein’s insanity) Thank You Very Much

Learn How to Beat Problems Feb23, 2007

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

Similaire à Learn How to Beat Problems Feb23, 2007

Similaire à Learn How to Beat Problems Feb23, 2007 (20)

Dernier

Dernier (20)

Learn How to Beat Problems Feb23, 2007